Teleflex (TFX)
(Delayed Data from NYSE)
$201.92 USD
-1.58 (-0.78%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $201.74 -0.18 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$201.92 USD
-1.58 (-0.78%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $201.74 -0.18 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
Can Myriad Genetics (MYGN) Spring a Surprise in Q4 Earnings?
by Zacks Equity Research
Myriad Genetics (MYGN) is well poised to deliver favorable results in Q4 riding on a diversified portfolio with products like Vectra DA test.
Can CVS Health (CVS) Pull a Surprise this Earnings Season?
by Zacks Equity Research
CVS Health (CVS) is poised to gain on strong Pharmacy Services numbers that benefited from the upside in Specialty Pharmacy in Q2.
Why Earnings Season Could Be Great for Teleflex Incorporated (TFX)
by Zacks Equity Research
Teleflex Incorporated (TFX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP ahead of earnings.
MedTech Stocks to Top Q2 Estimates
by Zacks Equity Research
Most of the MedTech majors are lined up to report their earnings results over the next week.
What's in the Cards for DaVita (DVA) this Earnings Season?
by Zacks Equity Research
Despite a stable Kidney Care business, escalating expenses is likely to mar DaVita's (DVA) performance in the second quarter.
Boston Scientific (BSX) Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.
LabCorp (LH) Q2 Earnings: Is Disappointment in the Cards?
by Zacks Equity Research
With the Covance Drug Diagnostic arm's revenue and margins projected to decline further, LabCorp???s business in Q2 might face disruption.
What's in Store for athenahealth (ATHN) in Q2 Earnings?
by Zacks Equity Research
athenahealth Inc. (ATHN) is set to report second-quarter 2017 results on Jul 20.
Will Intuitive Surgical (ISRG) Surprise in Q2 Earnings?
by Zacks Equity Research
Intuitive Surgical Inc. (ISRG) is scheduled to report second-quarter 2017 results after the closing bell on Jul 20.
Will Thermo Fisher's (TMO) Q2 Earnings Surpass Expectations?
by Zacks Equity Research
Strong focus on product launch and emerging market expansion should drive Thermo Fisher (TMO) toward an earnings beat in Q2.
Can Abbott Laboratories (ABT) Pull a Surprise in Q2 Earnings?
by Zacks Equity Research
Abbott Laboratories (ABT) is scheduled to report second-quarter 2017 results before the opening bell on Jul 20.
Zacks Industry Outlook Highlights: Teleflex, Medtronic, Johnson & Johnson, Hologic and Wright Medical
by Zacks Equity Research
Zacks Industry Outlook Highlights: Teleflex, Medtronic, Johnson & Johnson, Hologic and Wright Medical
Teleflex to Introduce Arrow AC3 Optimus at EuroPCR, Paris
by Zacks Equity Research
Teleflex Inc. (TFX) announced plans to introduce Arrow AC3 Optimus Intra-Aortic Balloon Pump at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR) in Paris during May 16--19.
Medical Product Stocks' Earnings Due on May 4: ABMD & More
by Zacks Equity Research
Here we discuss four major Medical Product bigwigs, which are scheduled to release their earnings results on May 4.
Invest in These Top 4 GARP Stocks Now
by Zacks Equity Research
The GARP approach prefers stocks that are priced below the market or any reasonable target determined by fundamental analysis.
After ISRG Q1 Earnings, 3 Medical Instrument Stocks Looking Up
by Zacks Equity Research
While the Medical Instrument industry has been oscillating between hope and despair, let us take a look at three stocks which are expected to put up an impressive show this earnings season like Intuitive Surgical.
Teleflex (TFX) Acquires Medical Device Provider Pyng Medical
by Zacks Equity Research
Teleflex Inc. (TFX), a global provider of medical technologies, announced that it has acquired Pyng Medical Corporation.
Moving Average Crossover Alert: Teleflex (TFX)
by Zacks Equity Research
Teleflex (TFX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
Teleflex (TFX) Gains FDA Approval for TrapLiner Catheter
by Zacks Equity Research
Teleflex Incorporated (TFX) recently announced 510(k) clearance for its TrapLiner Catheter from the US FDA for a full fledged commercial launch in the country.
MedTech Stocks' Earnings Due on Feb 23: TFX, SAUHF, BIO, PDCO
by Zacks Equity Research
Let's take a look at the major MedTech stocks slated to release their Oct-Dec 2016 numbers on Feb 23.
Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS
by Zacks Equity Research
Teleflex Inc. (TFX) recently announced the launch of LMA Gastro Airway with Cuff Pilot Technology and the receipt of 510(k) approval from the U.S. FDA for its Arrow VPS Rhythm device.
Company News for December 05, 2016
by Zacks Equity Research
Companies in the News are: BIG,VASC,TFX,P,SIRI,SBUX